1,376 results on '"Angioedemas, hereditary"'
Search Results
2. A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)
3. Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II (KONFIDENT-KID)
4. HAELO: a Phase 3 Study to Evaluate NTLA-2002 in Participants with Hereditary Angioedema (HAE)
5. A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean People (SPEAKUP)
6. An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema
7. A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)
8. A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China
9. CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema
10. Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks
11. Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks
12. A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
13. Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema (RAPIDe-3)
14. Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)
15. Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
16. A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
17. Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults with HAE (CHAPTER-4)
18. Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (HAE CHAPTER-1)
19. Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE (CHAPTER-3)
20. Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)
21. A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II (ENABLE)
22. Berotralstat Treatment in Children With Hereditary Angioedema (APeX-P)
23. Long-Term Follow-Up (LTFU) of Subjects Treated with NTLA 2002
24. OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)
25. Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients with Hereditary Angioedema (RAPIDe-2)
26. A Survey of Icatibant in Pediatric Participants with Hereditary Angioedema
27. FIRAZYR General Drug Use-Results Survey (Japan)
28. Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat
29. NTLA-2002 in Adults With Hereditary Angioedema (HAE) (NTLA-2002)
30. Institutional Registry of Rare Diseases
31. A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home
32. A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada (PROSPECT)
33. A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland (CHOPIN)
34. A Survey of Lanadelumab in Participants With Hereditary Angioedema
35. A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
36. PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
37. A Study of STAR-0215 in Participants With Hereditary Angioedema
38. Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies (APeX-A)
39. A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor
40. A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema (HAErmony-1)
41. Social Evaluated Cold Pressor Test in Hereditary Angioedema Patients (FROSEN)
42. Donidalorsen Expanded Access Program for Patients With Hereditary Angioedema
43. Autonomic Nervous System Profile in Hereditary Angioedema (ANS-HAE)
44. Patient Registry to Evaluate the Real-world Safety of Ruconest®
45. Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
46. Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan (APeX-J)
47. C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
48. A Study of STAR-0215 in Healthy Adult Participants
49. Angioedema Biomarker Research Study
50. The Role of the Coagulation Pathways in Recurrent Angioedema (Angiocoag)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.